Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Both oral contraceptives reduced hirsutism in PCOS patients, but adding metformin showed no extra benefit.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Antibiotic ointment and petrolatum ointment heal wounds similarly; iron deficiency isn't linked to certain hair loss in women; griseofulvin and terbinafine are equally effective for fungal scalp infections but work better on different types.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Minoxidil shortens baldness from chemotherapy by 50.2 days without significant side effects.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Different types of polycystic ovary syndrome show varying levels of insulin resistance, with the 'PHO' type being the most insulin resistant.

The patient has frontal fibrosing alopecia (FFA).

Frontal fibrosing alopecia and ulerythema ophryogenes may be related and can evolve from one to the other.

Hair loss from genetics and hormones can be treated with drugs or surgery.

Diagnosing Polycystic Ovary Syndrome is hard due to varying symptoms, no set criteria, and the need for better tests and education.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Treat hair loss with medicine, continue indefinitely.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Finasteride may help treat frontal fibrosing alopecia, but more research is needed.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

A young woman had a rare tumor causing high male hormone levels and symptoms like excessive hair and acne. After removing the tumor, her hormone levels returned to normal. Early diagnosis is important.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.